$IMCR 8-K SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Regulation FD Disclosure Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
06 Aug 2026	8-K: Results of Operations and Financial Condition
27 May 2026	8-K: Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Results of Operations and Financial Condition
25 Feb 2026	8-K: Results of Operations and Financial Condition
30 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
09 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
28 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation
06 Nov 2025	8-K: Results of Operations and Financial Condition
07 Aug 2025	8-K: Results of Operations and Financial Condition
15 May 2025	8-K: Submission of Matters to a Vote of Security Holders
07 May 2025	8-K: Results of Operations and Financial Condition
17 Mar 2025	8-K: Other Events
10 Mar 2025	8-K: Regulation FD Disclosure
26 Feb 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
10 Jan 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
02 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
08 Nov 2024	8-K: Termination of a Material Definitive Agreement
06 Nov 2024	8-K: Results of Operations and Financial Condition
16 Sep 2024	8-K: Other Events

Comments